Postpoliomyelitis syndrome

Postpoliomyelitis syndrome (PPS), also known as post-polio syndrome or postpolio sequelae, is a condition that affects survivors of acute paralytic poliomyelitis, typically developing 15 to 40 years after the initial poliovirus infection. It is characterized by new or progressive neuromuscular symptoms that occur in individuals who had previously achieved neurological stability following their acute polio illness. The condition primarily affects the neuromuscular system, resulting from ongoing degeneration of motor neurons that were damaged during the original poliovirus infection and had partially recovered through compensatory reinnervation of muscle fibers. Key clinical features include new progressive muscle weakness, muscle atrophy, generalized fatigue (both central and peripheral), muscle and joint pain (myalgia and arthralgia), cold intolerance, and decreased functional capacity. Some patients may also experience respiratory insufficiency, dysphagia (swallowing difficulties), and sleep disturbances. The weakness tends to affect muscles that were previously involved during the acute polio episode, though previously unaffected muscles may also be involved. Symptoms are often exacerbated by physical overexertion, emotional stress, and cold temperatures. There is currently no cure or specific disease-modifying treatment for postpoliomyelitis syndrome. Management is primarily supportive and multidisciplinary, focusing on symptom relief and preservation of function. This includes carefully supervised, non-fatiguing exercise programs, energy conservation strategies, assistive devices and orthotics, weight management, pain management, and respiratory support when needed. Intravenous immunoglobulin (IVIg) has been investigated in clinical trials with some evidence of modest benefit in reducing pain and improving quality of life, though it is not universally recommended. Physical and occupational therapy play central roles in maintaining mobility and independence.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Postpoliomyelitis syndrome